Placental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population

Placental angiogenic biomarkers, including soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), are used to predict preeclampsia (PE) and related adverse outcomes . This study aimed to assess differences in sFlt-1/PlGF ratios among high-risk women according to PE, maternal and neonatal morbidity, and to evaluate the predictive performance of thresholds > 38 and > 85, including time to delivery. In this retrospective cohort study, 289 high-risk singleton pregnant women (2015−2019) were included. sFlt-1/PlGF ratios were measured after 24 weeks of gestation and compared across outcome groups. sFlt-1/PlGF ratios were significantly lower in the reference group compared to the confirmed and the suspected PE group. Ratios > 38 were associated with PE (OR 12.2 (95% CI 4.9−30.7; p < 0.001)), maternal morbidity (OR 22.5 (95% CI 8.9−56.7; p < 0.001)), neonatal morbidity (OR 4.0 (95% CI 2.0−8.0; p < 0.001)) and delivery within one, two, and three weeks (OR 20.0, 9.2, and 14.6; all p < 0.001). The sFlt-1/PlGF ratio supports individualized management in high-risk pregnancies.

Authors

Publication Details

Journal
Figshare
Published
2026-11-13
DOI
https://doi.org/10.6084/m9.figshare.35000245
Primary Topic
Pregnancy and preeclampsia studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Placental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population

E. Lodewijks, M. L. E. Hendrix, H. C. J. Scheepers, J. A. P. Bons et al.
Figshare
Pregnancy and preeclampsia studies
article

Placental angiogenic biomarkers for triage of suspected preeclampsia and prediction of maternal and neonatal morbidity in a high-risk population

E. Lodewijks, M. L. E. Hendrix, H. C. J. Scheepers, J. A. P. Bons, M. J. M. Suiters, S. Al-Nasiry
article en

Abstract

Placental angiogenic biomarkers, including soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), are used to predict preeclampsia (PE) and related adverse outcomes . This study aimed to assess differences in sFlt-1/PlGF ratios among high-risk women according to PE, maternal and neonatal morbidity, and to evaluate the predictive performance of thresholds > 38 and > 85, including time to delivery. In this retrospective cohort study, 289 high-risk singleton pregnant women (2015−2019) were included. sFlt-1/PlGF ratios were measured after 24 weeks of gestation and compared across outcome groups. sFlt-1/PlGF ratios were significantly lower in the reference group compared to the confirmed and the suspected PE group. Ratios > 38 were associated with PE (OR 12.2 (95% CI 4.9−30.7; p < 0.001)), maternal morbidity (OR 22.5 (95% CI 8.9−56.7; p < 0.001)), neonatal morbidity (OR 4.0 (95% CI 2.0−8.0; p < 0.001)) and delivery within one, two, and three weeks (OR 20.0, 9.2, and 14.6; all p < 0.001). The sFlt-1/PlGF ratio supports individualized management in high-risk pregnancies.

Figshare
Good health and well-being
Pregnancy and preeclampsia studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon